APA
Neviani P., Harb J. G., Oaks J. J., Santhanam R., Walker C. J., Ellis J. J., Ferenchak G., Dorrance A. M., Paisie C. A., Eiring A. M., Ma Y., Mao H. C., Zhang B., Wunderlich M., May P. C., Sun C., Saddoughi S. A., Bielawski J., Blum W., Klisovic R. B., Solt J. A., Byrd J. C., Volinia S., Cortes J., Huettner C. S., Koschmieder S., Holyoake T. L., Devine S., Caligiuri M. A., Croce C. M., Garzon R., Ogretmen B., Arlinghaus R. B., Chen C., Bittman R., Hokland P., Roy D., Milojkovic D., Apperley J., Goldman J. M., Reid A., Mulloy J. C., Bhatia R., Marcucci G. & Perrotti D. (20131126). PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. : The Journal of clinical investigation.
Chicago
Neviani Paolo, Harb Jason G, Oaks Joshua J, Santhanam Ramasamy, Walker Christopher J, Ellis Justin J, Ferenchak Gregory, Dorrance Adrienne M, Paisie Carolyn A, Eiring Anna M, Ma Yihui, Mao Hsiaoyin C, Zhang Bin, Wunderlich Mark, May Philippa C, Sun Chaode, Saddoughi Sahar A, Bielawski Jacek, Blum William, Klisovic Rebecca B, Solt Janelle A, Byrd John C, Volinia Stefano, Cortes Jorge, Huettner Claudia S, Koschmieder Steffen, Holyoake Tessa L, Devine Steven, Caligiuri Michael A, Croce Carlo M, Garzon Ramiro, Ogretmen Besim, Arlinghaus Ralph B, Chen Ching-Shih, Bittman Robert, Hokland Peter, Roy Denis-Claude, Milojkovic Dragana, Apperley Jane, Goldman John M, Reid Alistair, Mulloy James C, Bhatia Ravi, Marcucci Guido and Perrotti Danilo. 20131126. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. : The Journal of clinical investigation.
Harvard
Neviani P., Harb J. G., Oaks J. J., Santhanam R., Walker C. J., Ellis J. J., Ferenchak G., Dorrance A. M., Paisie C. A., Eiring A. M., Ma Y., Mao H. C., Zhang B., Wunderlich M., May P. C., Sun C., Saddoughi S. A., Bielawski J., Blum W., Klisovic R. B., Solt J. A., Byrd J. C., Volinia S., Cortes J., Huettner C. S., Koschmieder S., Holyoake T. L., Devine S., Caligiuri M. A., Croce C. M., Garzon R., Ogretmen B., Arlinghaus R. B., Chen C., Bittman R., Hokland P., Roy D., Milojkovic D., Apperley J., Goldman J. M., Reid A., Mulloy J. C., Bhatia R., Marcucci G. and Perrotti D. (20131126). PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. : The Journal of clinical investigation.
MLA
Neviani Paolo, Harb Jason G, Oaks Joshua J, Santhanam Ramasamy, Walker Christopher J, Ellis Justin J, Ferenchak Gregory, Dorrance Adrienne M, Paisie Carolyn A, Eiring Anna M, Ma Yihui, Mao Hsiaoyin C, Zhang Bin, Wunderlich Mark, May Philippa C, Sun Chaode, Saddoughi Sahar A, Bielawski Jacek, Blum William, Klisovic Rebecca B, Solt Janelle A, Byrd John C, Volinia Stefano, Cortes Jorge, Huettner Claudia S, Koschmieder Steffen, Holyoake Tessa L, Devine Steven, Caligiuri Michael A, Croce Carlo M, Garzon Ramiro, Ogretmen Besim, Arlinghaus Ralph B, Chen Ching-Shih, Bittman Robert, Hokland Peter, Roy Denis-Claude, Milojkovic Dragana, Apperley Jane, Goldman John M, Reid Alistair, Mulloy James C, Bhatia Ravi, Marcucci Guido and Perrotti Danilo. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. : The Journal of clinical investigation. 20131126.